APA

Balleari E., Rossi E., Clavio M., Congiu A., Gobbi M., Grosso M., Secondo V., Spriano M., Timitilli S. & Ghio R. (20060413). Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study. : Annals of hematology.

Chicago

Balleari Enrico, Rossi Edoardo, Clavio Marino, Congiu Angela, Gobbi Marco, Grosso Marco, Secondo Vincenzo, Spriano Mauro, Timitilli Silvana and Ghio Riccardo. 20060413. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study. : Annals of hematology.

Harvard

Balleari E., Rossi E., Clavio M., Congiu A., Gobbi M., Grosso M., Secondo V., Spriano M., Timitilli S. and Ghio R. (20060413). Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study. : Annals of hematology.

MLA

Balleari Enrico, Rossi Edoardo, Clavio Marino, Congiu Angela, Gobbi Marco, Grosso Marco, Secondo Vincenzo, Spriano Mauro, Timitilli Silvana and Ghio Riccardo. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study. : Annals of hematology. 20060413.